Journal of the American Chemical Society
Page 4 of 5
Organic Synthesis with Diazo Compounds: From Cyclopropanes to Ylides;
Wiley: New York, 1998. (b) Doyle, M. P.; Protopopova, M. N. Tetrahedron
1998, 54, 7919. (c) Denmark, S. E.; Beutner, G. In Cycloaddition Reactions
in Organic Synthesis; Kobayashi, S., Jørgensen, K. A., Eds.; Wiley-VCH:
Weinheim, Germany, 2002; pp 85ff. (d) Lebel, H.; Marcoux, J.-F.; Molinaro,
C.; Charette, A. B. Chem. Rev. 2003, 103, 977. (e) Lou, Y.; Horikawa, M.;
Kloster, R. A.; Hawryluk, N. A.; Corey, E. J. J. Am. Chem. Soc. 2004, 126,
8916. (f) Goudreau, S. R.; Charette, A., B. J. Am. Chem. Soc. 2009, 131,
15633. (g) Zhu, S.; Cui, X.; Zhang, X. P. Eur. J. Inorg. Chem. 2012, 430.
(h) Wang, Y.; Wen, X.; Cui, X.; Wojtas, L.; Zhang, X. P. J. Am. Chem. Soc.
2017, 139, 1049.
1
2
3
4
5
6
7
8
In summary, we have developed a new class of chiral mono-
protected aminoethyl amine ligands which enable the
enantioselective C–H activation of free carboxylic acids without
using exogenous directing groups. Enantioselective C–H
arylation of simple cyclopropanecarboxylic acid and phthalyl-
protected 2-aminoisobutyric acid provides a new synthetic
disconnection for the asymmetric synthesis of diverse chiral
carboxylic acids. The successful design of this new ligand to
match the weakly coordinating carboxylic acid for stereocontrol
offers a framework for understanding the chiral induction in
C(sp3)–H activation.
(9) Talele, T. T. J. Med. Chem. 2016, 59, 8712.
(10)For Pd(0) and Rh(I)-catalyzed intramolecular enantioselective C–H
functionalization of cyclopropanes, see (a) Saget, T.; Cramer, N. Angew.
Chem., Int. Ed. 2012, 51, 12842. (b) Pedroni, Saget, T.; Donets, P. A.;
Cramer, N. Chem. Sci. 2015, 6, 5164; (c) Pedroni, J.; Cramer, N. Angew.
Chem. Int. Ed. 2015, 54, 11826; (d) Lee, T.; Hartwig, J. F. Angsew. Chem.,
Int. Ed. 2016, 55, 8723; (e) Ladd, C. L.; Charette, A. B. Org. Lett. 2016, 18,
6046. (f) Pedroni, J.; Cramer, N. J. Am. Chem. Soc. 2017, 139, 12398.
(11)Peretto, I.; Radaelli, S.; Parini, C.: Zandi, M.; Raveglia, L. F.; Dondio, G.;
Fontanella, L.; Misiano, P.; Bigogno, C.; Rizz, A.; Riccardi, B.; Biscaioli,
M.; Marchetti, S.; Puccini, P.; Catinella, S.; Rondelli, I.; Cenacchi, V.;
Bolzoni, P. T.; Caruso, P.; Villetti, G.; Facchinetti, F.; Del Giudice, E.;
Moretto, N.; Imbimbo, B.P. J. Med. Chem. 2005, 48, 5705.
(12)(a) MITSUBISHI TANABE PHARMA CORPORATION; Sakurai, O.;
Saruta, K; Hayashi, N.; Goi, T; Morokuma, K.; Tsujishima, H.; Sawatomo,
H.; Shitama, H.; Imashiro, R. WO Patent 2012/81736, 2012. (b) Edgar, D.
M.; Hangauer, D. G.; Shiosaki, K.; Solomon, M.; White, J. F. US Patent
2006/63755, 2006.
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Acknowledgments. We gratefully acknowledge The Scripps
Research Institute, the NIH (NIGMS 2R01 GM084019) and
Shanghai RAAS Blood Products Co. Ltd. for financial support.
We thank Dr. Jason Chen from Automated Synthesis Facility,
The Scripps Research Institute for his assistance with 2D
HPLC/SFC analysis. This communication is dedicated to
Professor Elias J. Corey on the occasion of his 90th birthday.
(13)CHIESI FARMACEUTICI S.P.A. WO Patent 2004/74232, 2004.
Supporting Information Available: Experimental procedures
and spectral data for all new compounds (PDF). Crystallographic
data (CIF). These materials are available free of charge via the
References
(1) For selected reviews of enantioselective C–H Functionalization: (a) Giri, R.;
Shi, B.-F.; Engle, K. M.; Maugel, N.; Yu, J.-Q. Chem. Soc. Rev. 2009, 38,
3242. (b) Newton, C. G.; Wang, S.-G.; Oliveira, C. C.; Cramer, N. Chem.
Rev. 2017, 117, 8908. (c) Saint-Denis, T. G.; Zhu, R.-Y.; Chen, G.; Wu, Q.-
F.; Yu, J.-Q. Science 2018, 359, 759.
(2) (a) Wasa, M.; Engle, K. M.; Lin, D. W.; Yoo, E. J.; Yu, J.-Q. J. Am. Chem.
Soc. 2011, 133, 19598. (b) Xiao, K.-J.; Lin, D. W.; Miura, M.; Zhu, R.-Y.;
Gong, W.; Wasa, M.; Yu, J.-Q. J. Am. Chem. Soc. 2014, 136, 8138. (c) Chan,
K. S. L.; Fu, H.-Y.; Yu, J.-Q. J. Am. Chem. Soc. 2015, 137, 2042. (d) Chen,
G.; Gong, W.; Zhuang, Z.; Andra, M. S.; Chen, Y.-Q.; Hong, X.; Yang, Y.-
F.; Liu, T.; Houk, K. N.; Yu, J.-Q. Science 2016, 353, 1023. (e) Wu, Q.-F.;
Shen, P.-X.; He, J.; Wang, X.-B.; Zhang, F.; Shao, Q.; Zhu, R.-Y.; Mapelli,
C.; Qiao, J. X.; Poss, M. A.; Yu, J.-Q. Science 2017, 355, 499.
(3) For the preliminary result of enantioselective C(sp3)–H functionalization
using mono-N-protected amino acid ligands (MPAA) and pyridine directing
group: Shi, B.-F.; Maugel, N.; Zhang, Y.-H.; Yu, J.-Q. Angew. Chem., Int.
Ed. 2008, 47, 4882.
(4) For selected Pd(0)-catalyzed intramolecular enantioselective C–H
functionalization see: (a) Nakanishi, M.; Katayev, D.; Besnard, C.; Kꢀndig,
E. P. Angew. Chem., Int. Ed. 2011, 50, 7438. (b) Anas, S.; Cordi, A.; Kagan,
H. B. Chem. Commun. 2011, 47, 11483. (c) Saget, T.; Lémouzy, N.; Cramer,
N. Angew. Chem., Int. Ed. 2012, 51, 2238. (d) Martin, N.; Pierre, C.; Davi,
M.; Jazzar, R.; Baudoin, O. Chem. Eur. J. 2012, 18, 4480. (e) Zhu, C.; Wang,
D.; Zhao, Y.; Sun, W.-Y.; Shi, Z. J. Am. Chem. Soc. 2017, 139, 16486.
(5) For Pd (II)-catalyzed enantioselective C–H functionalization using
phosphoric acids/amides ligands (a) Yan, S.-B.; Zhang, S.; Duan, W.- L.
Org. Lett. 2015, 17, 2458. (b) Wang, H.; Tong, H.-R.; He, G.; Chen, G.
Angew. Chem., Int. Ed. 2016, 55, 15387. (c) Jain, P.; Verma, P.; Xia, G.; Yu,
J.-Q. Nat. Chem. 2016, 353, 1023.
(6) Young, I. S.; Baran, P. S. Nat. Chem. 2009, 1, 193.
(7) (a) Giri, R.; Maugel, N.; Li, J.-J.; Wang, D.-H.; Breazzano, S. P.; Saunder,
L. B.; Yu, J.-Q. J. Am. Chem. Soc. 2007, 129, 3510. (b) Chen, G.; Zhuang,
Z.; Li, G.-C.; Saint-Denis, T. G.; Xiao, Y.; Joe, C. L.; Yu, J.-Q. Angew.
Chem., Int. Ed. 2017, 56, 1506. (c) Zhu, Y.; Chen, X.; Yuan, C.; Li, G.;
Zhang, J.; Zhao, Y. Nat. Commun. 2017, 8, 14904. (d) Ghosh, K. K.; van
Gemmeren, Manual. Chem. Eur. J. 2017, 23, 17697.
(8) For selected reviews and reactions of asymmetric cyclopropanation, see: (a)
Doyle, M. P.; McKervey, M. A.; Ye, T. Modern Catalytic Methods for
ACS Paragon Plus Environment